Editorial Commentary
Balancing evidence and individualization in adjuvant CDK4/6 therapy
Translational Cancer Research
2025;
14
(8)
:4479-4481
.
(31 August 2025)
Liquid biopsy for the detection of non-viral head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(8)
:4482-4485
.
(31 August 2025)
Advancing RET-targeted therapy in thyroid cancer: insights and implications from the LIBRETTO-001 study
Translational Cancer Research
2025;
14
(8)
:4486-4490
.
(31 August 2025)
Original Article
Identification of disulfidptosis-related long non-coding RNA signature to predict the prognosis, immunotherapy, and chemotherapy options in acute myeloid leukemia
Translational Cancer Research
2025;
14
(8)
:4491-4506
.
(31 August 2025)
Exploration of the mechanism of curcumin in the regulation of apoptosis for the treatment of colorectal cancer
Translational Cancer Research
2025;
14
(8)
:4507-4519
.
(31 August 2025)
Development and validation of an immune-related gene signature for the prognostic and immune landscape prediction in head and neck squamous cell carcinoma by integrated analysis of machine learning and Mendelian randomization
Translational Cancer Research
2025;
14
(8)
:4520-4538
.
(31 August 2025)
A novel prognostic model based on endoplasmic reticulum stress-associated E3 ligases and deubiquitinating enzymes in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(8)
:4539-4548
.
(31 August 2025)
Overexpression of miR-1283 inhibits cell proliferation and migration of colorectal cancer cells by targeting PDZD8
Translational Cancer Research
2025;
14
(8)
:4549-4560
.
(31 August 2025)
METTL11A serves as a novel therapeutic target for acute myeloid leukemia through regulation of the p38-MAPK pathway
Translational Cancer Research
2025;
14
(8)
:4561-4573
.
(31 August 2025)
Evaluating the efficacy of combined modality therapy versus chemotherapy alone in unresectable primary pulmonary diffuse large b-cell lymphoma: a retrospective cohort study
Translational Cancer Research
2025;
14
(8)
:4574-4585
.
(31 August 2025)
Enhanced antitumor efficacy of sorafenib and everolimus combination in pancreatic neuroendocrine neoplasms through mTOR inhibition
Translational Cancer Research
2025;
14
(8)
:4586-4597
.
(31 August 2025)
Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes
Translational Cancer Research
2025;
14
(8)
:4598-4620
.
(31 August 2025)
Untargeted metabolomics integrated with SHAP analysis identifies novel biomarkers of oxaliplatin induced peripheral neurotoxicity in gastric cancer
Translational Cancer Research
2025;
14
(8)
:4621-4637
.
(31 August 2025)
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning
Translational Cancer Research
2025;
14
(8)
:4638-4648
.
(31 August 2025)
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation
Translational Cancer Research
2025;
14
(8)
:4649-4661
.
(31 August 2025)
Thyroid differentiation score-related genes and prognostic model for thyroid cancer
Translational Cancer Research
2025;
14
(8)
:4662-4678
.
(31 August 2025)
Clinical immunotherapeutic significance of RAS gene mutations in melanoma
Translational Cancer Research
2025;
14
(8)
:4679-4690
.
(31 August 2025)
A novel risk score model incorporating six co-stimulatory molecules for accurate prognosis prediction of laryngeal cancer
Translational Cancer Research
2025;
14
(8)
:4691-4702
.
(31 August 2025)
Machine learning-based prognosis prediction for serous ovarian cancer using the SEER database and data from a single center in China
Translational Cancer Research
2025;
14
(8)
:4703-4719
.
(31 August 2025)
Exploration of signature-related FAM genes and correlation between FAM50A expression and the pathogenesis and prognosis of hepatocellular carcinoma
Translational Cancer Research
2025;
14
(8)
:4720-4747
.
(31 August 2025)
Risk factors and treatment strategies for female reproductive system carcinosarcoma with metastasis
Translational Cancer Research
2025;
14
(8)
:4748-4758
.
(31 August 2025)
Identification of hub genes related to radiosensitivity and prognosis in rectal cancer
Translational Cancer Research
2025;
14
(8)
:4759-4773
.
(31 August 2025)
Identification of metabolic driver genes and targeted drug screening for lung adenocarcinoma metastasis at the single-cell resolution
Translational Cancer Research
2025;
14
(8)
:4774-4790
.
(31 August 2025)
Diagnostic value of circulating tumor cells in gastric cancer: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(8)
:4791-4803
.
(31 August 2025)
Analysis of clinicopathological characteristics and prognosis of appendiceal neuroendocrine tumors: a retrospective cohort study based on the SEER database
Translational Cancer Research
2025;
14
(8)
:4804-4821
.
(31 August 2025)
RHOJ enhances adhesion and proliferation capabilities and suppresses apoptosis of melanoma cells by activating the Rap1 signaling pathway
Translational Cancer Research
2025;
14
(8)
:4822-4836
.
(31 August 2025)
Influential factors affecting the survival benefit of combined neoadjuvant therapy and esophagectomy in patients with esophageal cancer: an analysis based on the SEER database
Translational Cancer Research
2025;
14
(8)
:4837-4850
.
(31 August 2025)
Prognostic implication of endoplasmic reticulum stress-related gene signature in lung adenocarcinoma and its effect on tumor immunity
Translational Cancer Research
2025;
14
(8)
:4851-4866
.
(31 August 2025)
Pulmonary metastasis risk and overall survival score in choriocarcinoma: a novel nomogram-based risk assessment system
Translational Cancer Research
2025;
14
(8)
:4867-4881
.
(31 August 2025)
Role of the transcription factor SOX8 in hepatocellular carcinoma development and lymph node metastasis
Translational Cancer Research
2025;
14
(8)
:4882-4905
.
(31 August 2025)
Effects of different cancer-directed therapies on mortality of patients with stage I pulmonary large cell neuroendocrine carcinoma: a retrospective cohort study based on the SEER database
Translational Cancer Research
2025;
14
(8)
:4906-4919
.
(31 August 2025)
miR-378a-5p targets FGR to suppress proliferation, invasion and migration in lung adenocarcinoma cells
Translational Cancer Research
2025;
14
(8)
:4920-4938
.
(31 August 2025)
Inhibition of SLC25A10 promotes cellular senescence and impedes hepatocellular carcinoma progression
Translational Cancer Research
2025;
14
(8)
:4939-4954
.
(31 August 2025)
Diagnostic accuracy of SHOX-2 methylation for malignant pleural effusion: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(8)
:4955-4964
.
(31 August 2025)
Development and validation of a preoperative nomogram for predicting residual tumor risk in breast cancer patients undergoing excisional biopsy
Translational Cancer Research
2025;
14
(8)
:4965-4975
.
(31 August 2025)
Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death receptor-1 inhibitors for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(8)
:4976-4988
.
(31 August 2025)
An efficient epithelial-mesenchymal transition-related gene signature for predicting the survival of patients with lung adenocarcinoma
Translational Cancer Research
2025;
14
(8)
:4989-5001
.
(31 August 2025)
Acute radiation-induced brain injury in patients with glioma and the construction of a clinical prediction model: a cohort study
Translational Cancer Research
2025;
14
(8)
:5002-5011
.
(31 August 2025)
The functional role of exosomal miRNA-675-3p derived from patients with hepatocellular carcinoma
Translational Cancer Research
2025;
14
(8)
:5012-5027
.
(31 August 2025)
ISG20L2 as a driver in the proliferation and invasion of lung adenocarcinoma via NKX2-1 regulation
Translational Cancer Research
2025;
14
(8)
:5028-5044
.
(31 August 2025)
Facilitation of natural killer T-cell cytotoxic activity in uterine sarcoma via the CKS2-PI3K-AKT-MICA axis
Translational Cancer Research
2025;
14
(8)
:5045-5058
.
(31 August 2025)
Comparisons of the efficacy of different Chinese medicine injections on immune function in patients with nasopharyngeal carcinoma during combined therapy: a systematic review and network meta-analysis
Translational Cancer Research
2025;
14
(8)
:5059-5076
.
(31 August 2025)
Value of ZSCAN9 in the treatment and survival prediction of hepatocellular carcinoma: a bioinformatics study
Translational Cancer Research
2025;
14
(8)
:5077-5092
.
(31 August 2025)
Microbial community profiles in breast cancer and normal adjacent tissues: associations with clinicopathological characteristics
Translational Cancer Research
2025;
14
(8)
:5093-5108
.
(31 August 2025)
Investigation into the sensitivity of adipocytes mediated by the major vault protein (MVP) to chemotherapy for triple-negative breast cancer
Translational Cancer Research
2025;
14
(8)
:5109-5126
.
(31 August 2025)
Elevated suicide risk in thyroid cancer patients: determining mortality rates and identifying predictive factors using Surveillance, Epidemiology, and End Results (SEER) data
Translational Cancer Research
2025;
14
(8)
:5127-5141
.
(31 August 2025)
Classification of chemoradiotherapy sensitivity in hypopharyngeal squamous cell carcinoma based on deep-learning and radiomics feature fusion
Translational Cancer Research
2025;
14
(8)
:5142-5154
.
(31 August 2025)
A development and validation of predictive model based on novel immune-related gene-based subtypes for the risk assessment of cutaneous melanoma
Translational Cancer Research
2025;
14
(8)
:5155-5165
.
(31 August 2025)
Identification of mechanosensitive ion channel-related molecular subtypes and key genes for ovarian cancer
Translational Cancer Research
2025;
14
(8)
:5166-5175
.
(31 August 2025)
Retraction
Retraction: Expression of centrosomal protein 55 in glioma tissue and the influence on glioma cell functions
Translational Cancer Research
2025;
14
(8)
:5176
.
(31 August 2025)
Retraction: MicroRNA-494 represses osteosarcoma development by modulating ASK-1 related apoptosis complexes
Translational Cancer Research
2025;
14
(8)
:5177
.
(31 August 2025)
